These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35850052)

  • 1. Effect of Baricitinib on the epithelial-mesenchymal transition of alveolar epithelial cells induced by IL-6.
    Liu Y; Hu M; Fan G; Xing N; Zhang R
    Int Immunopharmacol; 2022 Sep; 110():109044. PubMed ID: 35850052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-27 inhibits the TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells.
    Dong Z; Tai W; Lei W; Wang Y; Li Z; Zhang T
    BMC Cell Biol; 2016 Mar; 17():7. PubMed ID: 26932661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
    Deepak HB; Prince SE; Deshpande P
    Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
    Weston S; Macdonald JL; Williams LM; Roussou E; Kang NV; Kiriakidis S; Taylor PC
    Clin Exp Rheumatol; 2022 Sep; 40(9):1620-1628. PubMed ID: 34665696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-206 overexpression inhibits epithelial-mesenchymal transition and glomerulosclerosis in rats with chronic kidney disease by inhibiting JAK/STAT signaling pathway.
    Zhao SQ; Shen ZC; Gao BF; Han P
    J Cell Biochem; 2019 Sep; 120(9):14604-14617. PubMed ID: 31148248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
    Dang C; Lu Y; Chen X; Li Q
    Front Immunol; 2021; 12():650708. PubMed ID: 33927721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells.
    Aota K; Yamanoi T; Kani K; Ono S; Momota Y; Azuma M
    Inflammation; 2021 Feb; 44(1):206-216. PubMed ID: 32772240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells protect from hypoxia-induced alveolar epithelial-mesenchymal transition.
    Uzunhan Y; Bernard O; Marchant D; Dard N; Vanneaux V; Larghero J; Gille T; Clerici C; Valeyre D; Nunes H; Boncoeur E; Planès C
    Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(5):L439-51. PubMed ID: 26702148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
    Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
    Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
    Yang T; Chen M; Sun T
    Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.
    Montero P; Milara J; Roger I; Cortijo J
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.
    Kachroo P; Lee MH; Zhang L; Baratelli F; Lee G; Srivastava MK; Wang G; Walser TC; Krysan K; Sharma S; Dubinett SM; Lee JM
    J Exp Clin Cancer Res; 2013 Nov; 32(1):97. PubMed ID: 24274066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
    Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-23 amplifies the epithelial-mesenchymal transition of mechanically conditioned alveolar epithelial cells in rheumatoid arthritis-associated interstitial lung disease through mTOR/S6 signaling.
    Zhang C; Wang S; Lau J; Roden AC; Matteson EL; Sun J; Luo F; Tschumperlin DJ; Vassallo R
    Am J Physiol Lung Cell Mol Physiol; 2021 Dec; 321(6):L1006-L1022. PubMed ID: 34585990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Liuweibuqi Capsules in Pulmonary Alveolar Epithelial Cells and COPD Through JAK/STAT Pathway.
    Wang C; Ding H; Tang X; Li Z; Gan L
    Cell Physiol Biochem; 2017; 43(2):743-756. PubMed ID: 28950251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
    Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
    Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen sulfide attenuates paraquat-induced epithelial-mesenchymal transition of human alveolar epithelial cells through regulating transforming growth factor-β1/Smad2/3 signaling pathway.
    Bai YW; Ye MJ; Yang DL; Yu MP; Zhou CF; Shen T
    J Appl Toxicol; 2019 Mar; 39(3):432-440. PubMed ID: 30265375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRF1 Mediates Growth Arrest and the Induction of a Secretory Phenotype in Alveolar Epithelial Cells in Response to Inflammatory Cytokines IFNγ/TNFα.
    Recchia Luciani G; Barilli A; Visigalli R; Sala R; Dall'Asta V; Rotoli BM
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes.
    Joyo Y; Kawaguchi Y; Yonezu H; Senda H; Yasuma S; Shiraga H; Nozaki M; Aoyama M; Asai K; Murakami H; Waguri-Nagaya Y
    Immunol Res; 2022 Apr; 70(2):208-215. PubMed ID: 35014010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.